Immunological veterinary medicinal products, including vaccines, are authorised for sheep.
Search results 26 to 29 from a total of 29
| Name | Description | Marketing Authorisation Holder | License Number | License Date | Animal | Further Information |
|---|---|---|---|---|---|---|
|
Zulvac 1+8 Ovis |
Blauzungenkrankheit, Serotypen 1 und 8 |
Zoetis Belgium S.A., Belgien |
EU/2/11/120/001-003 | 14.03.2011 | Schaf | |
|
Zulvac 8 Ovis |
Blauzungenkrankheit, Serotyp 8 |
Zoetis Belgium S.A., Belgien |
EU/2/09/104/001-002 | 15.03.2010 | Schaf | |
|
Zulvac BTV |
Blauzungenkrankheit, Serotypen 1, 4 oder 8 |
Zoetis Belgium S.A., Belgien |
EU/2/17/207/001-009 | 25.04.2017 | Rind, Schaf | |
|
Zulvac SBV |
Infektion mit dem Schmallenbergvirus |
Zoetis Belgium S.A., Belgien |
EU/2/14/178/001 | 06.02.2015 | Schaf, Rind |
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 515 in BAnz AT 09.04.2024 B3.
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.
Updated: 09.04.2024
